文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

衰弱、器官支持与重症COVID-19患者长期生存的关联

Association of Frailty, Organ Support, and Long-Term Survival in Critically Ill Patients With COVID-19.
PubMed 文献 · Crit Care Explor · 2022-05-25
一句话结论重症COVID-19患者中约五分之一存在衰弱(CFS≥5),衰弱与6个月生存率降低独立相关,且与因难治性器官衰竭而放弃升级器官支持的决策相关。

该研究为前瞻性纵向队列的辅助研究,纳入巴西圣保罗某大学医院ICU收治的1028例重症COVID-19患者,平均年龄66岁,男性占61%。采用临床衰弱量表(CFS,1-9分,≥5分为衰弱)评估基线衰弱,并以经验证的衰弱指数(0-1,>0.25为衰弱)作为参照。结果显示224例(22%)患者衰弱,608例(59%)在6个月随访期内死亡;衰弱与6个月生存率降低独立相关,并可在年龄和SOFA评分相似的患者中进一步区分死亡风险;CFS识别衰弱的AUC为0.91(95%CI 0.89-0.93)。作者认为临床医生应将衰弱与社会人口学和临床指标结合,以更全面判断COVID-19重症预后。

要点

  • 1028例重症COVID-19患者中224例(22%)基线CFS≥5(衰弱),608例(59%)在6个月随访期内死亡。
  • 衰弱与6个月生存率降低独立相关,并可在年龄和SOFA评分相似的患者中进一步区分死亡风险。
  • CFS识别衰弱(以衰弱指数>0.25定义)的准确度高,AUC为0.91(95%CI 0.89-0.93)。
  • 不同衰弱状态患者的治疗方式无差异,但CFS评分越高,越常因难治性器官衰竭而放弃器官支持。
  • 作者认为临床医生应将衰弱与社会人口学和临床指标结合,以更全面判断COVID-19危重症预后。

适用人群与场景

  • 巴西圣保罗某大学医院ICU收治的重症COVID-19患者,共1028例,平均年龄66岁,男性占61%。

诊断标准与关键阈值

  • 衰弱评估:临床衰弱量表(CFS)1-9分,≥5分定义为衰弱。
  • 衰弱指数:0-1分,>0.25定义为衰弱,作为CFS识别衰弱的参照标准。

研究设计与关键结果

  • 研究设计:前瞻性纵向队列的辅助研究,单中心(巴西圣保罗某大学医院),纳入1028例重症COVID-19 ICU患者,无干预。
  • 衰弱患病率:224例(22%)患者CFS≥5(衰弱)。
  • 6个月随访期内608例(59%)死亡。
  • 衰弱与6个月生存率降低独立相关,并可在年龄和SOFA评分相似的患者中进一步区分死亡风险(Cox模型)。
  • CFS识别衰弱(衰弱指数>0.25)的AUC为0.91(95%CI 0.89-0.93)。
  • 不同衰弱状态患者的治疗方式无差异,但CFS评分越高,越常因难治性器官衰竭而放弃器官支持。

证据类型、等级与局限

  • 证据类型:前瞻性纵向队列的辅助研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,临床医生应将衰弱与社会人口学和临床指标结合,以更全面判断COVID-19危重症预后。
  • CFS评分≥5与较低的长期生存率及因多器官衰竭放弃进一步升级有创支持的决策相关,可用于ICU收治的重症COVID-19患者的预后分层。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: Few studies have explored the effect of frailty on the long-term survival of COVID-19 patients after ICU admission. Furthermore, the Clinical Frailty Scale (CFS) validity in critical care patients remains debated. We investigated the association between frailty and 6-month survival in critically ill COVID-19 patients. We also explored whether ICU resource utilization varied according to frailty status and examined the concurrent validity of the CFS in this setting.

DESIGN: Ancillary study of a longitudinal prospective cohort.

SETTING: University hospital in São Paulo.

PATIENTS: Patients with severe COVID-19 admitted to ICU.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: We assessed baseline frailty using the CFS (1-9; frail ≥ 5) and used validated procedures to compute a Frailty Index (0-1; frail > 0.25). We used Cox models to estimate associations of frailty status with 6-month survival after ICU admission and area under the receiver operating characteristic curves (AUCs) to estimate CFS's accuracy in identifying frailty according to Frailty Index. We included 1,028 patients (mean age, 66 yr; male, 61%). Overall, 224 (22%) patients were frail (CFS ≥ 5), and 608 (59%) died over the 6-month follow-up. Frailty was independently associated with lower 6-month survival and further stratified mortality in patients with similar age and Sequential Organ Failure Assessment scores. We additionally verified that the CFS was highly accurate in identifying frailty as defined by the Frailty Index (AUC, 0.91; 95% CI, 0.89-0.93). Although treatment modalities did not diverge according to frailty status, higher CFS scores were associated with withholding organ support due to refractory organ failure.

CONCLUSIONS: One in five COVID-19 patients admitted to the ICU was frail. CFS scores greater than or equal to 5 were associated with lower long-term survival and decisions on withholding further escalation of invasive support for multiple organ failure in the ICU. Clinicians should consider frailty alongside sociodemographic and clinical measures to have a fuller picture of COVID-19 prognosis in critical care.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Taniguchi LU, Avelino-Silva TJ, Dias MB, et al. Association of Frailty, Organ Support, and Long-Term Survival in Critically Ill Patients With COVID-19. Crit Care Explor. 2022. PMID: 35765375. doi:10.1097/CCE.0000000000000712

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。